rs193922689

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2

The NM_001079802.2(FKTN):​c.166-4A>G variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00084 in 1,553,096 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00080 ( 2 hom. )

Consequence

FKTN
NM_001079802.2 splice_region, intron

Scores

2
Splicing: ADA: 0.9986
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:10B:4

Conservation

PhyloP100: 3.96

Publications

2 publications found
Variant links:
Genes affected
FKTN (HGNC:3622): (fukutin) The protein encoded by this gene is a putative transmembrane protein that is localized to the cis-Golgi compartment, where it may be involved in the glycosylation of alpha-dystroglycan in skeletal muscle. The encoded protein is thought to be a glycosyltransferase and could play a role in brain development. Defects in this gene are a cause of Fukuyama-type congenital muscular dystrophy (FCMD), Walker-Warburg syndrome (WWS), limb-girdle muscular dystrophy type 2M (LGMD2M), and dilated cardiomyopathy type 1X (CMD1X). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2010]
FKTN Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2M
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • myopathy caused by variation in FKTN
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy 1X
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001079802.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FKTN
NM_001079802.2
MANE Select
c.166-4A>G
splice_region intron
N/ANP_001073270.1O75072-1
FKTN
NM_001351496.2
c.166-4A>G
splice_region intron
N/ANP_001338425.1O75072-1
FKTN
NM_006731.2
c.166-4A>G
splice_region intron
N/ANP_006722.2O75072-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FKTN
ENST00000357998.10
TSL:5 MANE Select
c.166-4A>G
splice_region intron
N/AENSP00000350687.6O75072-1
FKTN
ENST00000223528.6
TSL:1
c.166-4A>G
splice_region intron
N/AENSP00000223528.2O75072-1
FKTN
ENST00000602526.1
TSL:1
n.*86-4A>G
splice_region intron
N/AENSP00000473347.1R4GMU0

Frequencies

GnomAD3 genomes
AF:
0.00119
AC:
181
AN:
152196
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00480
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00173
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000761
AC:
185
AN:
243196
AF XY:
0.000851
show subpopulations
Gnomad AFR exome
AF:
0.000128
Gnomad AMR exome
AF:
0.0000588
Gnomad ASJ exome
AF:
0.000607
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00297
Gnomad NFE exome
AF:
0.00101
Gnomad OTH exome
AF:
0.000336
GnomAD4 exome
AF:
0.000802
AC:
1124
AN:
1400782
Hom.:
2
Cov.:
25
AF XY:
0.000873
AC XY:
611
AN XY:
700228
show subpopulations
African (AFR)
AF:
0.0000619
AC:
2
AN:
32330
American (AMR)
AF:
0.0000677
AC:
3
AN:
44286
Ashkenazi Jewish (ASJ)
AF:
0.000703
AC:
18
AN:
25614
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39314
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84464
European-Finnish (FIN)
AF:
0.00291
AC:
154
AN:
52860
Middle Eastern (MID)
AF:
0.000192
AC:
1
AN:
5200
European-Non Finnish (NFE)
AF:
0.000850
AC:
900
AN:
1058524
Other (OTH)
AF:
0.000791
AC:
46
AN:
58190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
53
106
158
211
264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00119
AC:
181
AN:
152314
Hom.:
2
Cov.:
33
AF XY:
0.00133
AC XY:
99
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41580
American (AMR)
AF:
0.0000653
AC:
1
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00480
AC:
51
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00174
AC:
118
AN:
68008
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00156
Hom.:
0
Bravo
AF:
0.000552

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
4
1
not provided (5)
-
2
-
Cardiovascular phenotype (2)
-
1
1
not specified (2)
-
1
-
Dilated cardiomyopathy 1X (1)
-
-
1
FKTN-related disorder (1)
-
1
-
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (1)
-
1
-
Myopathy caused by variation in FKTN (1)
-
-
1
Walker-Warburg congenital muscular dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
25
DANN
Benign
0.96
PhyloP100
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.81
SpliceAI score (max)
0.85
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.85
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193922689; hg19: chr9-108363422; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.